CD44-specific antibody treatment and CD44 deficiency exert distinct effects on leukocyte recruitment in experimental arthritis

Blood

Volumn 112, Issue 13, 2008, Pages 4999-5006

  Hutás, Gábor ^a   Bajnok, Éva ^a   Gál, István ^a   Finnegan, Alison ^b   Glant, Tibor T ^a   Mikecz, Katalin ^a,c  

^a Section of Sports Medicine   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; GR 1; GR 1 ANTIBODY; HERMES ANTIGEN; IM 7; KM 81; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD44; UNCLASSIFIED DRUG; CHEMOKINE RECEPTOR; GR 1 PROTEIN, MOUSE; GR-1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; BLOOD CLOTTING; CELL SURFACE; CONTROLLED STUDY; CROSS LINKING; FEMALE; GRANULOCYTE; JOINT SWELLING; LEUKOCYTE; LEUKOPENIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BAGG ALBINO MOUSE; CELL ADHESION; DISEASE MODEL; DRUG EFFECT; IMMUNOLOGY; INFLAMMATION; LEUKOCYTE ROLLING; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; THROMBOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD44; ARTHRITIS; BLOOD PLATELETS; CELL ADHESION; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; FEMALE; GRANULOCYTES; INFLAMMATION; LEUKOCYTE ROLLING; LEUKOCYTES; MICE; MICE, INBRED BALB C; RECEPTORS, CHEMOKINE;

EID: 58149382597     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-04-150383     Document Type: Article

References (40)

1. Lesley J, Hyman R. CD44 structure and function. Frontiers Biosci. 1998;3:616-630.
2. DeGrendele HC, Estess P, Picker LJ, Siegelman MH. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte- endothelial cell primary adhesion pathway. J Exp Med. 1996;183:1119-1130.
3. AruffoA, Stamenkovic I, MelnickM, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 1990;61:1303-1313.
4. Dimitroff CJ, Lee JY, Fuhlbrigge RC, Sackstein R. Adistinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells. Proc Natl Acad Sci USA. 2000;97:13841-13846.
5. Hidalgo A, Peired AJ, Wild MK, Vestweber D, Frenette PS. Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44. Immunity. 2007;26: 477-489.
6. Nandi A, Estess P, Siegelman M. Bimolecular complex between rolling and firm adhesion receptors required for cell arrest: CD44 association with VLA-4 in T cell extravasation. Immunity. 2004;20:455-465.
7. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.
8. Mikecz K, Brennan FR, Kim JH, Glant TT. Anti-CD44 treatment abrogates tissue edema and leukocyte infiltration in murine arthritis. Nat Med. 1995;1:558-563.
9. Mikecz K, Dennis K, Shi M, Kim JH. Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis. Arthritis Rheum. 1999;42:659-668.
10. Naor D, Nedvetzki S, Assayag N, et al. The mechanism of molecular redundancy in autoimmune inflammation in the context of CD44 deficiency. Ann N Y Acad Sci. 2005;1050:52-63.
11. Weiss L, Slavin S, Reich S, et al. Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody. Proc Natl Acad Sci USA. 2000;97:285-290.
12. 4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc Natl Acad Sci USA. 1999;96:6896-6901.
13. Katoh S, Matsumoto N, Kawakita K, et al. Arole for CD44 in an antigen-induced murine model of pulmonary eosinophilia. J Clin Invest. 2003;111: 1563-1570.
14. DeGrendele HC, Estess P, Siegelman MH. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science. 1997;278: 672-675.
15. Stoop R, Kotani H, McNeish JD, Otterness IG, Mikecz K. Increased resistance to collagen-induced arthritis in CD44-deficient DBA/1 mice. Arthritis Rheum. 2001;44:2922-2931.
16. Glant TT, Finnegan A, Mikecz K. Proteoglycan-induced arthritis: immune regulation, cellular mechanisms and genetics. Crit Rev Immunol. 2003;23:199-250.
17. Szanto S, Gal I, Gonda A, Glant TT, Mikecz K. Expression of L-selectin, but not CD44, is required for early neutrophil extravasation in antigen-induced arthritis. J Immunol. 2004;172:6723-6724.
18. Gal I, Bajnok E, Szanto S, et al. Visualization and in situ analysis of leukocyte trafficking into the ankle joint in a systemic murine model of rheumatoid arthritis. Arthritis Rheum. 2005;52:3269-3278.
19. Khan AI, Kerfoot SM, Heit B, et al. Role of CD44 and hyaluronan in neutrophil recruitment. J Immunol. 2004;173:7594-7601.
20. Gonda A, Gal I, Szanto S, et al. CD44, but not L-selectin, is critically involved in leucocyte migration into the skin in a murine model of allergic dermatitis. Exp Dermatol. 2005;14:700-708.
21. Zheng Z, Katoh S, He Q, et al. Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J Cell Biol. 1995;130:485-495.
22. Baatz H, Steinbauer M, Harris AG, Krombach F. Kinetics of white blood cell staining by intravascular administration of rhodamine 6G. Int J Microcirc Clin Exp. 1995;15:85-91.
23. Siegelman MH, DeGrendele HC, Estess P.Acti-vation and interaction of CD44 and hyaluronan in immunological systems. J Leukoc Biol. 1999;66: 315-321.
24. Wipke BT, Allen PM. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol. 2001;167:1601-1608.
25. Thakur ML, Li J, Chandy B, John EK, Gibbons G. Transient neutropenia: neutrophil distribution and replacement. J Nucl Med. 1996;37:489-494.
26. Fleming TJ, Fleming M, Malek TR. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow: RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J Immunol. 1993;151: 2399-2408.
27. Evangelista V, Manarini S, Sideri R, et al. Platelet/ polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation- dependent CD11b/CD18 adhesion. Role of PSGL-1 as a signaling molecule. Blood. 1999;93: 876-885.
28. Andre P, Hartwell D, Hrachovinova I, Saffaripour S, Wagner DD. Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci U S A. 2000;97:13835-13840.
29. Norman KE, Cotter MJ, Stewart JB, et al. Combined anticoagulant and antiselectin treatments prevent lethal intravascular coagulation. Blood. 2003;101:921-928.
30. Puré E, Cuff CA. A crucial role for CD44 in inflammation. Trends Mol Med. 2001;7:213-221.
31. Verdrengh M, Holmdahl R, TarkowskiA. Administration of antibodies to hyaluronanreceptor (CD44) delays the start and ameliorates the severity of collagen II arthritis. Scand J Immunol. 1995;42:353-358.
32. Nedvetzki S, Walmsley M, Alpert E, et al. CD44 involvement in experimental collagen-induced arthritis (CIA). J Autoimmun. 1999;13:39-47.
33. Lesley J, Gal I, Mahoney DJ, et al. TSG-6 modulates the interaction between hyaluronan and cell surface CD44. J Biol Chem. 2004;279:25745-25754.
34. Milner CM, Day AJ. TSG-6: a multifunctional protein associated with inflammation. J Cell Sci. 2003;116:1863-1873.
35. Sarraj B, Ludanyi K, Glant TT, Finnegan A, Mikecz K. Expression of CD44 and L-selectin in the innate immune system is required for severe joint inflammation in the proteoglycan-induced murine model of rheumatoid arthritis. J Immunol. 2006;177:1932-1940.
36. Taher TEI, Smits L, Griffioen AW, et al. Signaling through CD44 is mediated by tyrosine kinases. J Biol Chem. 1996;271:2863-2867.
37. Li R, Wong N, Jabali MD, Johnson P. CD44-initiated cell spreading induces pyk2 phosphoryla-tion, is mediated by src family kinases, and is negatively regulated by CD45. J Biol Chem. 2001;276:28767-28773.
38. Piccardoni P, Sideri R, Manarini S, et al. Platelet/ polymorphonuclear leukocyte adhesion: a new role for SRC kinases in Mac-1 adhesive function triggered by P-selectin. Blood. 2001;98:108-116.
39. Flick MJ, Du X, Degen JL. Fibrin(ogen)-alpha M beta 2 interactions regulate leukocyte function and innate immunity in vivo. Exp Biol Med (May-wood). 2004;229:1105-1110.
40. Santos LL, Morand EF, Hutchinson P, Boyce NW, Holdsworth SR. Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis. Clin Exp Immunol. 1997;107:248-253.